Literature DB >> 9831669

Herpes simplex type II and Mycoplasma genitalium as risk factors for heterosexual HIV transmission: report from the heterosexual HIV transmission study.

G Perez1, J H Skurnick, T N Denny, R Stephens, C A Kennedy, N Regivick, A Nahmias, F K Lee, S C Lo, R Y Wang, S H Weiss, D B Louria.   

Abstract

OBJECTIVES: Two hundred twenty-four human immunodeficiency virus (HIV) discordant couples (one HIV negative, one HIV positive) were compared with 78 seroconcordant heterosexually infected couples with HIV with regard to sexually transmitted diseases.
METHODS: Serologic testing and cultures were used to determine exposure of participants to sexually transmitted pathogens. These data were compared with HIV concordance of partners to investigate possible risk factors for HIV transmission.
RESULTS: Syphilis, chlamydia, and hepatitis B virus (HBV) serologies did not distinguish between concordant and discordant couples nor did cultures for Neisseria gonorrhoeae and Trichomonas or Chlamydia enzyme immunoassay (EIA). Risk of transmission increased with positive serologies for herpes simplex virus (HSV)-2 (P = 0.002), cytomegalovirus (CMV) (P = 0.04), and Mycoplasma genitalium (P = 0.01), but not with Mycoplasma fermentans or Mycoplasma penetrans. Cytomegalovirus was not a significant risk factor when controlled for HSV-2 status. Examination by partner status showed increased risk of concordance with: HSV-2 positive serology in both partners (odds ratio [OR] = 3.14; confidence interval [CI] = 1.62-6.09; P = 0.007); HSV-2 in female secondary partner (OR = 2.10; CI = 1.12-3.93; P = 0.02) or the male primary partner (OR = 2.15; CI = 1.15-4.02; P = 0.017); M. genitalium antibody in both partners (OR = 3.44; CI = 1.68-7.04; P < 0.001); M. genitalium antibody in the primary male partner (OR = 2.51, CI = 1. 27-4.91; P = 0.008) and M. genitalium antibody in the secondary female partner (OR = 2.52; CI = 1.21-5.23; P = 0.01).
CONCLUSIONS: These data support the role of HSV-2 in transmission of HIV and, for the first time, suggest a role for M. genitalium as an independent risk factor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9831669     DOI: 10.1016/s1201-9712(98)90088-1

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  20 in total

1.  The Interaction Between HIV and the Classic Sexually Transmitted Diseases.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

2.  Mycoplasma genitalium: an organism commonly associated with cervicitis among west African sex workers.

Authors:  J Pépin; A-C Labbé; N Khonde; S Deslandes; M Alary; A Dzokoto; C Asamoah-Adu; H Méda; E Frost
Journal:  Sex Transm Infect       Date:  2005-02       Impact factor: 3.519

3.  Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells.

Authors:  L A Morrison; L Zhu; L G Thebeau
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 4.  Mycoplasma genitalium: from Chrysalis to multicolored butterfly.

Authors:  David Taylor-Robinson; Jørgen Skov Jensen
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

5.  Prevalence and incidence of Mycoplasma genitalium in a cohort of HIV-infected and HIV-uninfected pregnant women in Cape Town, South Africa.

Authors:  Carolyn P Smullin; Hunter Green; Remco Peters; Dorothy Nyemba; Yamkela Qayiya; Landon Myer; Jeffrey Klausner; Dvora Joseph Davey
Journal:  Sex Transm Infect       Date:  2020-01-13       Impact factor: 3.519

6.  Extensive variation and rapid shift of the MG192 sequence in Mycoplasma genitalium strains from patients with chronic infection.

Authors:  Liang Ma; Miriam Mancuso; James A Williams; Barbara Van Der Pol; J Dennis Fortenberry; Qiuyao Jia; Leann Myers; David H Martin
Journal:  Infect Immun       Date:  2014-01-06       Impact factor: 3.441

7.  Histological Evidence of Chronic Mycoplasma genitalium-Induced Cervicitis in HIV-Infected Women: A Retrospective Cohort Study.

Authors:  Patricia M Dehon; Michael E Hagensee; Kimberly J Sutton; Hope E Oddo; Nia Nelson; Chris L McGowin
Journal:  J Infect Dis       Date:  2016-01-17       Impact factor: 5.226

Review 8.  Sexually transmitted infections of the anus and rectum.

Authors:  Roland Assi; Peter W Hashim; Vikram B Reddy; Hulda Einarsdottir; Walter E Longo
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

9.  Insights into Mycoplasma genitalium metabolism revealed by the structure of MG289, an extracytoplasmic thiamine binding lipoprotein.

Authors:  Katherine H Sippel; Balasubramanian Venkatakrishnan; Susan K Boehlein; Banumathi Sankaran; Jeanne G Quirit; Lakshamanan Govindasamy; Mavis Agbandje-McKenna; Steve Goodison; Charles J Rosser; Robert McKenna
Journal:  Proteins       Date:  2011-02

10.  Liposomal gD ectodomain (gD1-306) vaccine protects against HSV2 genital or rectal infection of female and male mice.

Authors:  K Olson; P Macias; S Hutton; W A Ernst; G Fujii; J P Adler-Moore
Journal:  Vaccine       Date:  2009-10-14       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.